z-logo
open-access-imgOpen Access
Obraz kliniczny guzów chromochłonnych u nosicieli mutacji protoonkogenu RET — badanie jednoośrodkowe
Author(s) -
Agnieszka Kotecka-Blicharz,
Kornelia Hasse-Lazar,
Beata JureckaLubieniecka,
Małgorzata OczkoWojciechowska,
Agnieszka Pawlaczek,
Beata Bugajska,
Aleksandra Ledwoń,
Aleksandra Król,
Barbara Michalik,
Barbara Jarząb
Publication year - 2016
Publication title -
endokrynologia polska
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.413
H-Index - 27
eISSN - 2299-8306
pISSN - 0423-104X
DOI - 10.5603/ep.2016.0008
Subject(s) - ret proto oncogene , medicine , pheochromocytoma , metanephrines , germline mutation , penetrance , multiple endocrine neoplasia type 2 , pathology , population , cohort , germline , mutation , gastroenterology , biology , genetics , gene , environmental health , phenotype
Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant genetic syndrome caused by germline mutation in RET proto-oncogene. The most common mutations are in a cysteine rich domain. Phaeochromocytoma will develop in approximately 50% of RET proto-oncogene carriers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom